News Archive | Novartis Philippines

Showing 130 results

November 2018

Media ReleaseNov 24, 2018
Sandoz Philippines hosts its first ever Heart, Mind and Brain Summit
Research shows that many individuals with cardiovascular disease have increased levels of depression and anxiety symptoms, while those who suffer from mental illness are at a higher risk of suffering…

October 2018

Media ReleaseOct 27, 2018
Sandoz, Novartis partner with specialists to hold Mental Health Law Forum
Makati City, 27 October 2018 – Sandoz Philippines and Novartis Healthcare Philippines, in partnership with the Philippine Neurological Association (PNA) and Philippine Psychiatric Association (PPA),…
Media ReleaseOct 02, 2018
Novartis receives Aon Special Recognition for Commitment to Leadership
Aon Best Employers program evaluates employee opinions to measure engagement, leadership, performance culture and employer brand The Peninsula Manila, October 2, 2018 – Novartis Healthcare…

August 2018

Media ReleaseAug 16, 2018
Sandoz Philippines names new Country Head
Makati City, August 16, 2018 - Sandoz Philippines Corporation, the local subsidiary of generics global leader Sandoz, has named Ms. Eleanor Lopez as Country Head effective August 1, 2018. Her…

July 2018

Media ReleaseJul 19, 2018
Novartis, ADB hold forum for CEOs of top Philippine hospitals
Themed “Creating Excellent Outcomes in the Philippine Healthcare System,” the Hospital CEO Forum 2018 is the first annual forum for CEOs of top hospitals in the Philippines. It aims to help co-…

June 2018

March 2018

Media ReleaseMar 15, 2018
Novartis renews partnership with Philippine Heart Center as Center of Excellence in Clinical Trials
Novartis Healthcare Philippines and the Philippine Heart Center (PHC) renewed their partnership in maintaining the hospital’s status as a center of excellence in clinical trials. The agreement aims…

February 2018

Media ReleaseFeb 19, 2018
Novartis’ TRANSFORM study confirms strong efficacy and significantly reduced infection rate of Everolimus-based regimen in transplant patients
Developed by Novartis, everolimus is approved in more than 100 countries to prevent organ rejection in adult heart and kidney transplant patients. It is also approved for liver transplant patients…

January 2018

Media ReleaseJan 28, 2018
Novartis Foundation joins new global partnership dedicated to accelerating leprosy eradication
Ahead of World Leprosy Day last January 28, 2018, the Novartis Foundation joined forces with other leading leprosy groups to launch a Global Partnership for Zero Leprosy to accelerate progress…

December 2017

Featured NewsDec 06, 2017
Sandoz Philippines hosts a scientific meeting on value-based medicine and biosimilars with Filipino oncologists

November 2017

Media ReleaseNov 08, 2017
Novartis promotes awareness on Dry Eye Syndrome, a common condition among Internet users
Makati City, November 8, 2017 – Filipinos spend more time on the Internet than people in any of the other 29 countries in Asia Pacific, the Middle East, North America and Europe profiled in the “…